白血病治療薬の世界市場：市場規模・現状・予測

• 英文タイトル：Global Leukemia Treatment Drugs Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03673 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、白血病治療薬の世界市場について調査・分析し、白血病治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（グリベック、サパシタビン、GA101、バサロキシン、トセドサット、レブリミド、ボスチニブ）、用途別（病院、研究機関、診断センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の白血病治療薬市場動向 ・主要企業別マーケットシェア ・白血病治療薬の種類別市場規模2014-2019 （グリベック、サパシタビン、GA101、バサロキシン、トセドサット、レブリミド、ボスチニブ） ・白血病治療薬の用途別市場規模2014-2019 （病院、研究機関、診断センター、その他） ・白血病治療薬の北米市場：主要企業・種類別/用途別市場規模 ・白血病治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・白血病治療薬の中国市場：主要企業・種類別/用途別市場規模 ・白血病治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・白血病治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・白血病治療薬のインド市場：主要企業・種類別/用途別市場規模 ・白血病治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GSK、Pfizer、Novartis AG、Roche、Celgene、Biogen、Genzyme Corporation、Eisai C.、Bristol Myers Squibb Company (BMS)） ・白血病治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Leukemia Treatment Drugs is used to cure Leukemia.Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market.
In 2018, the global Leukemia Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Leukemia Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Leukemia Treatment Drugs development in United States, Europe and China.

The key players covered in this study
GSK
Pfizer
Novartis AG
Roche
Celgene
Biogen
Genzyme Corporation
Eisai C.
Bristol Myers Squibb Company (BMS)

Market segment by Type, the product can be split into
Gleevec
Sapacitabine
GA101
Vasaroxine
Tosedosat
Revlimid
Bosutinib

Market segment by Application, split into
Hospitals
Research Institutes
Diagnostic Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Leukemia Treatment Drugs status, future forecast, growth opportunity, key market and key players.
To present the Leukemia Treatment Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Leukemia Treatment Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Leukemia Treatment Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Gleevec
1.4.3 Sapacitabine
1.4.4 GA101
1.4.5 Vasaroxine
1.4.6 Tosedosat
1.4.7 Revlimid
1.4.8 Bosutinib
1.5 Market by Application
1.5.1 Global Leukemia Treatment Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Research Institutes
1.5.4 Diagnostic Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Leukemia Treatment Drugs Market Size
2.2 Leukemia Treatment Drugs Growth Trends by Regions
2.2.1 Leukemia Treatment Drugs Market Size by Regions (2014-2025)
2.2.2 Leukemia Treatment Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Leukemia Treatment Drugs Market Size by Manufacturers
3.1.1 Global Leukemia Treatment Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Leukemia Treatment Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Leukemia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Leukemia Treatment Drugs Key Players Head office and Area Served
3.3 Key Players Leukemia Treatment Drugs Product/Solution/Service
3.4 Date of Enter into Leukemia Treatment Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Leukemia Treatment Drugs Market Size by Type (2014-2019)
4.2 Global Leukemia Treatment Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Leukemia Treatment Drugs Market Size (2014-2019)
5.2 Leukemia Treatment Drugs Key Players in United States
5.3 United States Leukemia Treatment Drugs Market Size by Type
5.4 United States Leukemia Treatment Drugs Market Size by Application

6 Europe
6.1 Europe Leukemia Treatment Drugs Market Size (2014-2019)
6.2 Leukemia Treatment Drugs Key Players in Europe
6.3 Europe Leukemia Treatment Drugs Market Size by Type
6.4 Europe Leukemia Treatment Drugs Market Size by Application

7 China
7.1 China Leukemia Treatment Drugs Market Size (2014-2019)
7.2 Leukemia Treatment Drugs Key Players in China
7.3 China Leukemia Treatment Drugs Market Size by Type
7.4 China Leukemia Treatment Drugs Market Size by Application

8 Japan
8.1 Japan Leukemia Treatment Drugs Market Size (2014-2019)
8.2 Leukemia Treatment Drugs Key Players in Japan
8.3 Japan Leukemia Treatment Drugs Market Size by Type
8.4 Japan Leukemia Treatment Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Leukemia Treatment Drugs Market Size (2014-2019)
9.2 Leukemia Treatment Drugs Key Players in Southeast Asia
9.3 Southeast Asia Leukemia Treatment Drugs Market Size by Type
9.4 Southeast Asia Leukemia Treatment Drugs Market Size by Application

10 India
10.1 India Leukemia Treatment Drugs Market Size (2014-2019)
10.2 Leukemia Treatment Drugs Key Players in India
10.3 India Leukemia Treatment Drugs Market Size by Type
10.4 India Leukemia Treatment Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Leukemia Treatment Drugs Market Size (2014-2019)
11.2 Leukemia Treatment Drugs Key Players in Central & South America
11.3 Central & South America Leukemia Treatment Drugs Market Size by Type
11.4 Central & South America Leukemia Treatment Drugs Market Size by Application

12 International Players Profiles
12.1 GSK
12.1.1 GSK Company Details
12.1.2 Company Description and Business Overview
12.1.3 Leukemia Treatment Drugs Introduction
12.1.4 GSK Revenue in Leukemia Treatment Drugs Business (2014-2019)
12.1.5 GSK Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Leukemia Treatment Drugs Introduction
12.2.4 Pfizer Revenue in Leukemia Treatment Drugs Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Company Details
12.3.2 Company Description and Business Overview
12.3.3 Leukemia Treatment Drugs Introduction
12.3.4 Novartis AG Revenue in Leukemia Treatment Drugs Business (2014-2019)
12.3.5 Novartis AG Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Leukemia Treatment Drugs Introduction
12.4.4 Roche Revenue in Leukemia Treatment Drugs Business (2014-2019)
12.4.5 Roche Recent Development
12.5 Celgene
12.5.1 Celgene Company Details
12.5.2 Company Description and Business Overview
12.5.3 Leukemia Treatment Drugs Introduction
12.5.4 Celgene Revenue in Leukemia Treatment Drugs Business (2014-2019)
12.5.5 Celgene Recent Development
12.6 Biogen
12.6.1 Biogen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Leukemia Treatment Drugs Introduction
12.6.4 Biogen Revenue in Leukemia Treatment Drugs Business (2014-2019)
12.6.5 Biogen Recent Development
12.7 Genzyme Corporation
12.7.1 Genzyme Corporation Company Details
12.7.2 Company Description and Business Overview
12.7.3 Leukemia Treatment Drugs Introduction
12.7.4 Genzyme Corporation Revenue in Leukemia Treatment Drugs Business (2014-2019)
12.7.5 Genzyme Corporation Recent Development
12.8 Eisai C.
12.8.1 Eisai C. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Leukemia Treatment Drugs Introduction
12.8.4 Eisai C. Revenue in Leukemia Treatment Drugs Business (2014-2019)
12.8.5 Eisai C. Recent Development
12.9 Bristol Myers Squibb Company (BMS)
12.9.1 Bristol Myers Squibb Company (BMS) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Leukemia Treatment Drugs Introduction
12.9.4 Bristol Myers Squibb Company (BMS) Revenue in Leukemia Treatment Drugs Business (2014-2019)
12.9.5 Bristol Myers Squibb Company (BMS) Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Leukemia Treatment Drugs Key Market Segments
Table Key Players Leukemia Treatment Drugs Covered
Table Global Leukemia Treatment Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Leukemia Treatment Drugs Market Size Market Share by Type 2014-2025
Figure Gleevec Figures
Table Key Players of Gleevec
Figure Sapacitabine Figures
Table Key Players of Sapacitabine
Figure GA101 Figures
Table Key Players of GA101
Figure Vasaroxine Figures
Table Key Players of Vasaroxine
Figure Tosedosat Figures
Table Key Players of Tosedosat
Figure Revlimid Figures
Table Key Players of Revlimid
Figure Bosutinib Figures
Table Key Players of Bosutinib
Table Global Leukemia Treatment Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Research Institutes Case Studies
Figure Diagnostic Centers Case Studies
Figure Others Case Studies
Figure Leukemia Treatment Drugs Report Years Considered
Table Global Leukemia Treatment Drugs Market Size 2014-2025 (Million US$)
Figure Global Leukemia Treatment Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Leukemia Treatment Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Leukemia Treatment Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Leukemia Treatment Drugs Market Share by Regions 2014-2019
Figure Global Leukemia Treatment Drugs Market Share by Regions 2014-2019
Figure Global Leukemia Treatment Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Leukemia Treatment Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Leukemia Treatment Drugs Market Share by Manufacturers (2014-2019)
Figure Global Leukemia Treatment Drugs Market Share by Manufacturers in 2018
Table Global Leukemia Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Leukemia Treatment Drugs Product/Solution/Service
Table Date of Enter into Leukemia Treatment Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Leukemia Treatment Drugs Market Size Share by Type (2014-2019)
Figure Global Leukemia Treatment Drugs Market Size Market Share by Type (2014-2019)
Table Global Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Leukemia Treatment Drugs Market Size Share by Application (2014-2019)
Figure Global Leukemia Treatment Drugs Market Size Market Share by Application (2014-2019)
Figure Global Leukemia Treatment Drugs Revenue Market Share by Application in 2018
Figure United States Leukemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Leukemia Treatment Drugs Market Share (2018-2019)
Table United States Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Leukemia Treatment Drugs Market Share by Type (2014-2019)
Table United States Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Leukemia Treatment Drugs Market Share by Application (2014-2019)
Figure Europe Leukemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Leukemia Treatment Drugs Market Share (2018-2019)
Table Europe Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Leukemia Treatment Drugs Market Share by Type (2014-2019)
Table Europe Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Leukemia Treatment Drugs Market Share by Application (2014-2019)
Figure China Leukemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Leukemia Treatment Drugs Market Share (2018-2019)
Table China Leukemia Treatment Drugs Market Size by Type (2014-20189) (Million US$)
Table China Leukemia Treatment Drugs Market Share by Type (2014-2019)
Table China Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table China Leukemia Treatment Drugs Market Share by Application (2014-2019)
Figure Japan Leukemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Leukemia Treatment Drugs Market Share (2018-2019)
Table Japan Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Leukemia Treatment Drugs Market Share by Type (2014-2019)
Table Japan Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Leukemia Treatment Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Leukemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Leukemia Treatment Drugs Market Share (2018-2019)
Table Southeast Asia Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Leukemia Treatment Drugs Market Share by Type (2014-2019)
Table Southeast Asia Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Leukemia Treatment Drugs Market Share by Application (2014-2019)
Figure India Leukemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Leukemia Treatment Drugs Market Share (2018-2019)
Table India Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table India Leukemia Treatment Drugs Market Share by Type (2014-2019)
Table India Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table India Leukemia Treatment Drugs Market Share by Application (2014-2019)
Figure Central & South America Leukemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Leukemia Treatment Drugs Market Share (2018-2019)
Table Central & South America Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Leukemia Treatment Drugs Market Share by Type (2014-2019)
Table Central & South America Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Leukemia Treatment Drugs Market Share by Application (2014-2019)
Table GSK Company Details
Table GSK Revenue in Leukemia Treatment Drugs Business (2014-2019) (Million US$)
Figure GSK Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019)
Table GSK Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$)
Figure Novartis AG Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019)
Table Novartis AG Recent Development
Table Roche Company Details
Table Roche Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019)
Table Roche Recent Development
Table Celgene Company Details
Table Celgene Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019)
Table Celgene Recent Development
Table Biogen Company Details
Table Biogen Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$)
Figure Biogen Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019)
Table Biogen Recent Development
Table Genzyme Corporation Company Details
Table Genzyme Corporation Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$)
Figure Genzyme Corporation Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019)
Table Genzyme Corporation Recent Development
Table Eisai C. Company Details
Table Eisai C. Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$)
Figure Eisai C. Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019)
Table Eisai C. Recent Development
Table Bristol Myers Squibb Company (BMS) Company Details
Table Bristol Myers Squibb Company (BMS) Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$)
Figure Bristol Myers Squibb Company (BMS) Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019)
Table Bristol Myers Squibb Company (BMS) Recent Development
Table Global Leukemia Treatment Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Leukemia Treatment Drugs Market Size Share by Regions (2019-2025)
Figure Global Leukemia Treatment Drugs Market Size Share by Regions in 2025
Figure United States Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Leukemia Treatment Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Leukemia Treatment Drugs Market Size by Product (2019-2025)
Figure Global Leukemia Treatment Drugs Market Size by Product in 2025
Table Global Leukemia Treatment Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Leukemia Treatment Drugs Market Size by Application (2019-2025)
Figure Global Leukemia Treatment Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---